Pharmacotherapy focusing on for the management of otitis media with effusion in children: Systematic review and meta-analysis.
Auris Nasus Larynx
; 49(5): 748-754, 2022 Oct.
Article
en En
| MEDLINE
| ID: mdl-35341623
OBJECTIVE: To examine the evidence for treating children with otitis media with effusion with pharmacotherapy. DATA SOURCES: For the systematic review, data were retrieved from PubMed, Cochrane database, and the Japan Medical Abstracts Society Database (1st January 1995 through 31th May 2019). STUDY SELECTION: Articles addressing pharmacotherapy for the management of otitis media with effusion in children were selected in English. DATA EXTRACTION: The database was searched using the keywords "Otitis Media with effusion or secretory otitis media" and the following medical agents: carbocysteine, antihistamines, leukotriene receptor antagonist, and steroid nasal spray. DATA SYNTHESIS: After a critical review of 18 studies, studies addressing steroid nasal spray were eligible for quantitative synthesis. Intranasal steroids for OME showed no benefit with OR 1.155 (95% CI 0.834-1.598) within one month. Conversely, intranasal steroids have effects for OME with OR 1.858 (95% CI 1.240-2.786) for more than one month. CONCLUSIONS: We found evidence of benefit from treatment of OME in children with intranasal steroids and S-carboxymethylcysteine at longer-term follow-up.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Otitis Media
/
Otitis Media con Derrame
Tipo de estudio:
Systematic_reviews
Límite:
Child
/
Humans
Idioma:
En
Revista:
Auris Nasus Larynx
Año:
2022
Tipo del documento:
Article
Pais de publicación:
Países Bajos